In vivo and in vitro infection with two different molecular clones of visna virus

Virology

Volumn 229, Issue 2, 1997, Pages 370-380

  Torsteinsdóttir, Sigurbjörg ^a   Agnarsdóttir, Gudrún ^a   Matthíasdóttir, Sigrídur ^a   Rafnar, Björg ^a   Andrésdóttir, Valgerdur ^a   Andrésson, Ólafur S ^a   Staskus, Katherine ^b   Pétursson, Gudmundur ^a   Pálsson, Páll A ^a   Georgsson, Gudmundur ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SHEEP; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VISNA VIRUS;

ANIMALIA; LENTIVIRUS; OVIS ARIES; VISNA VIRUS;

EID: 0031575843     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8428     Document Type: Article

References (51)

1. Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., Berger E. A. CC CKR5: A rantes, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage tropic HIV-1. Science. 272:1996;1955-1958.
2. Andrésson Ó. S., Elser J. E., Tobin G. J., Greenwood J. D., Gonda M. A., Georgsson G., Andrésdóttir V., Benediktsdóttir E., Carlsdóttir H. M., Mäntylä E. O., Rafnar B., Pálsson P. A., Casey J. W., Pétursson G. Nucleotide sequence and biological properties of a pathogenic proviral molecular clone of neurovirulent visna virus. Virology. 193:1993;89-105.
3. Asjö B., Albert J., Karlsson A., Morfeld-Manson L., Biberfeld G., Lidman K., Fenyo E. M. Replicative properties of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet. 2:1986;660-662.
4. Bøyum A. Isolation of mononuclear cells by combining centrifugation and sedimentation. Scand. J. Clin. Invest. 21:1968;77-89.
5. Cheng-Mayer C., Weiss C., Seto D., Levy J. A. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc. Natl. Acad. Sci. USA. 86:1989;8575-8579.
6. Cheng-Mayer C., Shioda T., Levy J. A. Host range, replicative and cytopatic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J. Virol. 65:1991;6931-6941.
7. Chowdhury I. H., Chao W., Potash M. J., Sova P., Gendelman H. E., Volsky D. J. vif. J. Virol. 70:1996;5336-5345.
8. Clavel F., Charneau P. Fusion from without directed by human immunodeficiency virus particles. J. Virol. 68:1994;1179-1185.
9. Cohen E. A., Dehni G., Sodroski J. G., Haseltine W. A. Human immunodeficiency virusvpr. J. Virol. 64:1990;3097-3099.
10. Crane S. E., Clements J. E., Narayan O. Separate epitopes in the envelope of visna virus are responsible for fusion and neutralization: Biological implications for anti-fusion antibodies in limiting virus replication. J. Virol. 62:1988;2680-2685.
11. Davis J. L., Clements J. E. Characterization of a cDNA clone encoding the visna virus transactivating protein. Proc. Natl. Acad. Sci. USA. 86:1989;414-418.
12. Deng H. K., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., DiMarzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
13. Dragic T., Litwin V., Allaway G. P., Martin S. R., Huang Y., Nagashima K. A., Cayanan C., Maddon P. J., Koup R. A., Moore J. P., Paxton W. A. HIV-entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
14. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
15. Fouchier R. A. M., Meyaard L., Brouwer M., Hovenkamp E., Schuitemaker H. Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell declinein vivo. Virology. 219:1996;87-95.
16. Gendelman H. E., Narayan O., Molineaux S., Clements J. E., Ghotbi Z. Slow, persistence of lentiviruses: Role of tissue macrophages and macrophage precursors in bone marrow. Proc. Natl. Acad. Sci. USA. 82:1985;7086-7090.
17. Gendelman H. E., Narayan O., Kennedy-Stoskopf S., Kennedy P. G., Ghotbi Z., Clements J. E., Stanley J., Pezeshkpour G. Tropism of sheep lentiviruses for monocytes: Susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J. Virol. 58:1986;67-74.
18. Gendelman H. E., Meltzer M. S. Mononuclear phagocytes and the human immunodeficiency virus. Curr. Op. Immunol. 2:1990;414-419.
19. Georgsson G., Houwers D. J., Pálsson P. A., Pétursson G. Expression of viral antigens in the central nervous system of visna-infected sheep: An immunohistochemical study on experimental visna induced by virus strains of increased neurovirulence. Acta Neuropathol. (Berl.). 77:1989;299-306.
20. Georgsson G., Pálsson P. A., Pétursson G. Some comparative aspects of visna and AIDS. Modern Pathology of AIDS and Other Retroviral Infections. 1990a;Basel, Karger. p. 82-98.
21. Georgsson G. Maedi-Visna: Pathology and Pathogenesis. Pétursson G., Hoff-Jörgensen R. Maedi-Visna and Related Diseases. 1990b;53-74 Kluwer Academic Pubs. Boston.
22. Gonda M. A., Wong-Staal F., Gallo R. C., Clements J. E., Narayan O., Gilden R. V. Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science. 227:1985;170-173.
23. Gudnadóttir M., Pálsson P. A. Successful transmission of visna by intrapulmonary inoculation. J. Infect. Dis. 115:1965;217-225.
24. Harter D. H., Choppin P. W. Cell-fusing activity of visna virus particles. Virology. 31:1967;279-288.
25. Hawkes R. A. Lennette E. H., Schmidt N. J. Viral, Rickettsial and Chlamydial Infections. 1979;32-35 Am. Public Health Assoc.
26. Houwers D. J., Gielkens A. L. J., Schaake J. Jr. An indirect enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to maedi visna virus. Vet. Microbiol. 7:1982;209-219.
27. Hwang S. S., Boyle T. J., Lyerly H. K., Cullen B. R. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science. 253:1991;71-74.
28. Kim F. M., Kolson D. L., Balliet J. W., Srinivasan A., Collman R. G. V3-independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate. J. Virol. 69:1995;1755-1761.
29. Lutley R. E., Pétursson G., Georgsson G., Pálsson P. A., Nathanson N. Strains of visna virus with increased neurovirulence. Sharp J. M., Hoff-Jørgensen R. Slow Viruses in Sheep, Goats and Cattle. 1985;45-49.
30. Malykh A., Reitz M. S., Louie A., Hall L., Lori F. Multiple determinants for growth of human immunodeficiency virus type 1 in monocyte-macrophages. Virology. 206:1995;646-650.
31. Miller M. D., Warmerdam M. T., Gaston I., Greene W. C., Feinberg M. B. The human immunodeficiency virus-1nef. J. Exp. Med. 179:1994;101-113.
32. Narayan O., Wolinsky J. S., Clements J. E., Strandberg J. D., Griffin D. E., Cork L. C. Slow virus replication: The role of macrophages in the persistence and expression of visna viruses of sheep and goats. J. Gen. Virol. 59:1982;345-356.
33. Narayan O., Clements J. E. Biology and pathogenesis of lentiviruses. J. Gen. Virol. 70:1989;1617-1639.
34. Nathanson N., Panitch H., Pálsson P. A., Pétursson G., Georgsson G. Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesions. Lab. Invest. 35:1976;444-451.
35. Nathanson N., Martin J. R., Georgsson G., Pálsson P. A., Lutley R. E., Pétursson G. The effect of post-infection immunization on the severity of experimental visna. J. Comp. Pathol. 91:1981;185-191.
36. Pétursson G., Nathanson N., Georgsson G., Panitch H., Pálsson P. A. Pathogenesis of visna. I. Sequential virologic, serologic and pathologic studies. Lab. Invest. 35:1976;402-412.
37. Pétursson G., Pálsson P. A., Georgsson G. Maedi-Visna in sheep: Host-virus interactions and utilization as a model. Intervirology. 30:1989;36-44.
38. Pétursson G. Experience with visna virus in Iceland. Björnsson J., Carp R. I., Löve A., Wisniewski H. M. Slow Infections of the Central Nervous System. The Legacy of Dr. Björn Sigurdsson. 1994;43-49 Ann. N.Y. Acad. Sci.
39. Potash M. J., Zeira M., Huang Z. B., Pearce T. E., Eden E., Gendelman H. E., Volsky D. J. Virus-cell membrane fusion does not predict efficient infection of alveolar macrophages by human immunodeficiency virus type 1 (HIV-1). Virology. 188:1992;864-868.
40. Sakai K., Ma X., Gordienko I., Volsky D. J. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolates: Role of the vif gene in HIV-1 infection kinetics and cytopathicity. J. Virol. 65:1991;5765-5773.
41. Saltarelli M., Querat G., Konings D. A. M., Vigne R., Clements J. E. Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology. 179:1990;347-364.
42. Sharma D. P., Zink M. C., Anderson M., Adams R., Clements J. E., Joag S. V., Narayan O. Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytotropic parental virus: Pathogenesis of infection in macaques. J. Virol. 66:1992;3550-3556.
43. Sigurdsson B., Thormar H., Pálsson P. A. Cultivation of visna virus in tissue culture. Arch. Gesamte Virusforsch. 10:1960;368-381.
44. Simmons G., McKnight A., Takeuchi Y., Hoshino H., Clapham P. R. Cell-to-cell fusion, but not virus entry in macrophages by T-cell line tropic HIV-1 strains: A V3 loop-determined restriction. Virology. 209:1995;696-700.
45. Sonigo P., Alizon M., Staskus K., Klatzmann D., Cole S., Danos O., Retzel E., Tiollais P., Haase A., Wain-Hobson S. Nucleotide sequence of the visna lentivirus: Relationship to the AIDS virus. Cell. 42:1985;369-382.
46. Staskus K. A., Retzel E. F., Lewis E. D., Silsby J. L., St. Cyr S., Rank J. M., Wietgrefe S. W., Haase A. T., Cook R., Fast D., Geiser P. T., Harty J. T., Kong S. H., Lahti C. J., Neufeld T. P., Porter T. E., Shoop E., Zachow K. R. Isolation of replication-competent molecular clones of visna virus. Virology. 181:1991;228-240.
47. Tersmette M., De Goede R. E. Y., Al B. J. M., Winkel I. N., Gruters R. A., Cuypers H. T. M., Huisman H. G., Miedema F. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62:1988;2026-2032.
48. Thormar H. A comparison of visna and maedi viruses I. Physical, chemical and biological properties. Res. Vet. Sci. 6:1965;117-128.
49. Torsteinsdóttir S., Georgsson G., Gísladóttir E., Rafnar B., Pálsson P. A., Pétursson G. Pathogenesis of central nervous system lesions in visna: Cell mediated immunity and lymphocyte subsets in blood, brain and cerebrospinal fluid. J. Neuroimmunol. 41:1992;149-158.
50. Traul K., Larson D., Stephens R., Wolff J., Munch K., Mayyasi S. New method for the removal of extraneous proteins from purified oncornaviruses. J. Clin. Microbiol. 2:1975;253-260.
51. Vigne R., Filippi P., Quérat G., Sauze N., Vitu C., Russo P., Delori P. Precursor polypeptides to structural proteins of visna virus. J. Virol. 42:1982;1046-1056.